Total Payments
$17,531
2024 Payments
$2,461
Companies
73
Transactions
1,185
Medicare Patients
3,620
Medicare Billing
$954,637
Payment Breakdown by Category
Food & Beverage$17,501 (99.8%)
Education$16.24 (0.1%)
Other$13.49 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $17,501 | 1,183 | 99.8% |
| Education | $16.24 | 1 | 0.1% |
| Entertainment | $13.49 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $2,920 | 179 | $0 (2024) |
| ABBVIE INC. | $2,074 | 106 | $0 (2024) |
| Janssen Biotech, Inc. | $1,678 | 161 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,436 | 92 | $0 (2024) |
| UCB, Inc. | $1,020 | 83 | $0 (2024) |
| PFIZER INC. | $634.22 | 76 | $0 (2024) |
| Radius Health, Inc. | $593.36 | 32 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $512.62 | 29 | $0 (2018) |
| ANI Pharmaceuticals, Inc. | $486.84 | 30 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $456.91 | 28 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,461 | 136 | Janssen Biotech, Inc. ($356.35) |
| 2023 | $2,717 | 148 | Novartis Pharmaceuticals Corporation ($366.89) |
| 2022 | $2,518 | 166 | Amgen Inc. ($487.54) |
| 2021 | $2,295 | 139 | AbbVie Inc. ($578.67) |
| 2020 | $1,656 | 103 | Amgen Inc. ($669.58) |
| 2019 | $1,754 | 122 | Amgen Inc. ($435.22) |
| 2018 | $1,924 | 175 | Janssen Biotech, Inc. ($298.00) |
| 2017 | $2,204 | 196 | E.R. Squibb & Sons, L.L.C. ($358.58) |
All Payment Transactions
1,185 individual payment records from CMS Open Payments — Page 1 of 48
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 12/20/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: Immunology | ||||||
| 12/19/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $20.80 | General |
| Category: Opioid Analgesic | ||||||
| 12/16/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $24.28 | General |
| Category: Endocrinology | ||||||
| 12/13/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $2.06 | General |
| Category: Immunology | ||||||
| 12/12/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $20.44 | General |
| Category: Dermatology | ||||||
| 12/11/2024 | SCILEX PHARMACEUTICALS INC. | GLOPERBA (Drug) | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: Analgesic | ||||||
| 12/09/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 12/07/2024 | SPR Therapeutics, Inc | SPRINT PNS System (Device) | Food and Beverage | Cash or cash equivalent | $77.00 | General |
| Category: Pain management | ||||||
| 12/05/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $22.91 | General |
| Category: Inflammation | ||||||
| 12/03/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/26/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $58.18 | General |
| Category: Opioid Analgesic | ||||||
| 11/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: RESPIRATORY | ||||||
| 11/19/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $8.67 | General |
| Category: Dermatology | ||||||
| 11/14/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $31.40 | General |
| Category: Immunology | ||||||
| 11/13/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $64.80 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 11/08/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $15.92 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $23.09 | General |
| Category: Dermatology | ||||||
| 11/05/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $17.28 | General |
| Category: Opioid Analgesic | ||||||
| 11/01/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $7.79 | General |
| Category: Immunology | ||||||
| 10/31/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/30/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $35.66 | General |
| Category: Immunology | ||||||
| 10/29/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: RESPIRATORY | ||||||
| 10/28/2024 | GENZYME CORPORATION | KEVZARA (Biological) | Food and Beverage | In-kind items and services | $23.06 | General |
| Category: Rheumatology | ||||||
| 10/24/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $21.34 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 967 | 3,045 | $676,241 | $249,245 |
| 2022 | 13 | 899 | 2,742 | $590,279 | $244,168 |
| 2021 | 12 | 776 | 2,275 | $443,322 | $196,654 |
| 2020 | 11 | 978 | 3,336 | $673,700 | $264,570 |
Total Patients
3,620
Total Services
11,398
Medicare Billing
$954,637
Procedure Codes
50
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 176 | 469 | $147,540 | $91,347 | 61.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 200 | 935 | $275,274 | $79,327 | 28.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 177 | 578 | $99,899 | $37,519 | 37.6% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 189 | 492 | $112,992 | $29,457 | 26.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 36 | 36 | $12,097 | $3,805 | 31.5% |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 21 | 27 | $5,600 | $2,184 | 39.0% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 19 | 33 | $5,029 | $1,636 | 32.5% |
| 20552 | Injection of trigger points, 1-2 muscles | Office | 2023 | 22 | 31 | $3,558 | $1,079 | 30.3% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 14 | 14 | $3,212 | $1,048 | 32.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 12 | 12 | $2,666 | $915.14 | 34.3% |
| 72100 | X-ray of lower and sacral spine, 2-3 views | Office | 2023 | 15 | 15 | $2,032 | $366.96 | 18.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 22 | 32 | $1,843 | $336.97 | 18.3% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 26 | 165 | $1,521 | $137.79 | 9.1% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2023 | 38 | 206 | $2,978 | $84.60 | 2.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 205 | 1,105 | $282,880 | $98,145 | 34.7% |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2022 | 178 | 439 | $131,700 | $85,794 | 65.1% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2022 | 192 | 494 | $98,800 | $29,918 | 30.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 136 | 315 | $43,497 | $19,051 | 43.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 59 | 59 | $17,523 | $6,557 | 37.4% |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2022 | 11 | 16 | $3,200 | $1,274 | 39.8% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 18 | 24 | $3,213 | $1,182 | 36.8% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 11 | 11 | $2,200 | $863.77 | 39.3% |
| 20552 | Injection of trigger points, 1-2 muscles | Office | 2022 | 15 | 19 | $1,881 | $671.36 | 35.7% |
| 72100 | X-ray of lower and sacral spine, 2-3 views | Office | 2022 | 13 | 13 | $1,560 | $355.34 | 22.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 15 | 22 | $1,100 | $222.31 | 20.2% |
About Dr. Jerome Watson, MD
Dr. Jerome Watson, MD is a Physical Medicine & Rehabilitation healthcare provider based in Statesville, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/17/2005. The National Provider Identifier (NPI) number assigned to this provider is 1336144138.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jerome Watson, MD has received a total of $17,531 in payments from pharmaceutical and medical device companies, with $2,461 received in 2024. These payments were reported across 1,185 transactions from 73 companies. The most common payment nature is "Food and Beverage" ($17,501).
As a Medicare-enrolled provider, Watson has provided services to 3,620 Medicare beneficiaries, totaling 11,398 services with total Medicare billing of $954,637. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Ad
Practice Information
- Specialty Physical Medicine & Rehabilitation
- Location Statesville, NC
- Active Since 06/17/2005
- Last Updated 01/04/2022
- Taxonomy Code 208100000X
- Entity Type Individual
- NPI Number 1336144138
Products in Payments
- Enbrel (Biological) $1,688
- Cimzia (Drug) $979.14
- SIMPONI ARIA (Biological) $796.65
- COSENTYX (Biological) $751.99
- COSENTYX (Drug) $684.40
- RINVOQ (Biological) $656.60
- PURIFIED CORTROPHIN GEL (Drug) $645.74
- Humira (Biological) $611.46
- TREMFYA (Drug) $520.20
- ORENCIA (Biological) $512.62
- EVENITY (Biological) $510.50
- BENLYSTA (Biological) $425.96
- OFEV (Drug) $397.15
- VIVLODEX (Drug) $385.56
- AVSOLA (Biological) $315.58
- OCTAGAM IMMUNE GLOBULIN (HUMAN) (Biological) $313.01
- Tymlos (Biological) $303.85
- LYRICA (Drug) $285.81
- RINVOQ (Drug) $267.77
- REMICADE (Biological) $259.70
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.